Stock Information
symbol line chart

FONRFonar Corp.

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Timothy R. Damadian

Location

New York, USA

Exchange

Nasdaq

Website

https://fonar.com

Summary

FONAR Corporation provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.

Company Info

CEO

Timothy R. Damadian

Location

New York, USA

Exchange

Nasdaq

Website

https://fonar.com

Summary

FONAR Corporation provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.

AI Insights for FONR
5 min read

Quick Summary

FONAR Corporation is a Melville, New York-based medical imaging company focused on MRI technology and diagnostic imaging services. The company is best known for its Upright MRI scanner, which allows patients to be scanned while standing, sitting, bending, leaning, or lying down. This positioning capability is designed to help physicians identify spine, joint, and other musculoskeletal conditions that may not be visible in traditional supine MRI scans. FONAR sells and services MRI equipment, but a large portion of its business comes from managing diagnostic imaging facilities through Health Management Company of America. Its main customers include diagnostic imaging centers, hospitals, physicians, patients needing advanced imaging, and third-party healthcare payors that reimburse MRI services.

Strengths

•

FONAR’s primary strength is its differentiated Upright MRI technology, which gives the company a specialized position within the broader MRI market.

•

The ability to scan patients in weight-bearing and multi-position conditions can provide clinical information that conventional MRI systems may miss.

•

The company also benefits from recurring revenue through its diagnostic imaging management business, which reduces dependence on sporadic scanner sales.

•

Its balance sheet and cash-flow profile have been viewed favorably by value-oriented investors, especially given the company’s low valuation multiples.

•

The pending $19.00 per-share cash acquisition proposal also validates that insiders and financing partners see meaningful value in the business.

Key Risks

•

The most immediate risk is that the proposed merger may fail to receive required stockholder approvals or could be delayed by litigation, regulatory review, or financing issues.

•

Because the transaction is led by insiders, the company may face scrutiny over valuation, process fairness, and conflicts of interest.

•

Operational risks include lower scan volumes, reimbursement cuts, insurance denials, wage inflation, facility cost increases, and competition from larger imaging providers.

•

FONAR’s equipment business may remain uneven because MRI scanner purchases are large, infrequent, and dependent on customer capital budgets.

What to Watch

During the most recent reported period, FONAR reported revenue of $26.472 million, gross profit of $11.241 million, operating income of $2.444 million, and net income of $2.328 million.
The company’s earnings per share were $0.07 on both a basic and diluted basis, while valuation metrics showed a low price-to-book ratio and relatively modest enterprise-value multiples.
The most important corporate event was the announcement of a definitive merger agreement dated December 23, 2025.
Under that agreement, an acquisition group led by CEO Timothy R.
Damadian and including certain management, board members, and third parties agreed to acquire the company in an all-cash transaction.
The agreement provides common stockholders with $19.00 per share and is expected to lead to delisting from Nasdaq if completed.

Price Drivers

•

FONAR’s stock price is being driven primarily by the announced all-cash merger agreement at $19.00 per common share.

•

The transaction price creates a clear reference point for the stock because investors are likely to compare the market price with the expected deal consideration.

•

Stockholder approval, the majority-of-disinterested-stockholders vote, regulatory filings, and litigation risk may affect the merger spread before closing.

•

Operating fundamentals also matter, including MRI scan volumes, reimbursement rates, margins, free cash flow, and demand for diagnostic imaging services.

•

Broader small-cap value sentiment, healthcare reimbursement policy, interest rates, and investor appetite for cash-generating micro-cap companies can also influence trading behavior.

Recent News

•

FONAR recently announced a definitive merger agreement under which FONAR, LLC and FONAR Acquisition Sub, Inc. would acquire the company in an all-cash transaction.

•

Common stockholders and Class B common stockholders are set to receive $19.00 per share if the deal closes.

•

The buyer group is led by CEO Timothy R.

•

Damadian and includes certain members of management, the board, and third parties.

•

A special committee of disinterested directors reviewed the transaction with independent advisors and recommended approval.

•

The company said the transaction is expected to close in FONAR’s third fiscal quarter of 2026, subject to stockholder approval and other customary conditions, after which the stock would be delisted from Nasdaq.

Market Trends

•

The diagnostic imaging market is supported by aging populations, rising chronic disease prevalence, and continued demand for noninvasive diagnostic tools.

•

MRI demand is expected to grow over time as physicians rely on advanced imaging for musculoskeletal, neurological, oncological, and cardiovascular evaluation.

•

At the same time, imaging providers face reimbursement pressure from insurers and government healthcare programs, which can reduce margins.

•

The market is increasingly influenced by artificial intelligence, faster scan protocols, workflow automation, and competition from large diversified equipment manufacturers.

•

Outpatient imaging centers remain an important trend because they can offer lower-cost and more convenient alternatives to hospital-based imaging, which benefits companies with exposure to managed imaging facilities.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on FONR

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show